Maria Teresa Cruz (MT Cruz) holds a degree in Pharmaceutical Sciences (1991) from the University of Lisbon, a master's in Drug Technologies (1996), and a PhD in Pharmacology (2004) at UC. She is an associate professor at the Faculty of Pharmacy and a Group Leader at the Centre for Innovative Biomedicine and Biotechnology (Immunometabolism and Stress Responses). She was Included in the "World's Top 2% Scientists" concerning the most cited researchers in 2022 and regularly reviews R&D projects for various institutions, including the Netherlands Organisation for Scientific Research, the French National Research Agency, Alzheimer's Association Research Fellowship Program, ERA4Health, External Expert for COST proposals evaluation, among others.
Maria Teresa Cruz (MT Cruz) holds a degree in Pharmaceutical Sciences (1991) from the University of Lisbon, a master's in Drug Technologies (1996), and a PhD in Pharmacology (2004) at UC. She is an associate professor at the Faculty of Pharmacy and a Group Leader at the Centre for Innovative Biomedicine and Biotechnology (Immunometabolism and Stress Responses). She was Included in the "World's Top 2% Scientists" concerning the most cited researchers in 2022 and regularly reviews R&D projects for various institutions, including the Netherlands Organisation for Scientific Research, the French National Research Agency, Alzheimer's Association Research Fellowship Program, ERA4Health, External Expert for COST proposals evaluation, among others.